Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
Li Zhou,1,* Yifeng Ren,2,* Xia Wang,1 Dongliu Miao,3 Analyn Lizaso,4 Haiyan Li,4 Han Han-Zhang,4 Jun Qian,1 Hui Yang11Oncology Department, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, Jiangsu, People’s Republic of China; 2Hepatobiliary and Pancreatic Surgery Depart...
Main Authors: | Zhou L, Ren Y, Wang X, Miao D, Lizaso A, Li H, Han-Zhang H, Qian J, Yang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-afatinib-in-a-her2-amplification-positive-endometrioid-ade-peer-reviewed-article-OTT |
Similar Items
-
Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring HER2 S310Y mutation: a case report
by: Gao Y, et al.
Published: (2018-12-01) -
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines
by: Simone Keller, et al.
Published: (2018-04-01) -
Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study
by: Zhengbo Song, et al.
Published: (2021-05-01) -
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib
by: Ines De Pauw, et al.
Published: (2019-01-01) -
Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review
by: Qu Y, et al.
Published: (2021-03-01)